Elimination of Cervical Cancer in Low-and Middle-Income Countries: Any Alternative to Pap Smear?

Authors

  • AE Ubom Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun state, Nigeria
  • CA Adepiti Faculty of Clinical Sciences, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria 2. Gynaecological Oncology Unit, Department of Obstetrics, Gynaecology and Perinatology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria https://orcid.org/0000-0001-7210-6670
  • OC Afon Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria https://orcid.org/0009-0001-9485-9208
  • EG Topcu 1. Safa Hospital, Istanbul, Turkey 2. World Association of Trainees in Obstetrics and Gynecology (WATOG), Paris, France https://orcid.org/0000-0003-1362-6224
  • P Roy 1. Roy’s Multispecialty Hospital, Siliguri, India 2. World Association of Trainees in Obstetrics and Gynecology (WATOG), Paris, France
  • F Ruiloba https://orcid.org/0000-0002-0491-3187

DOI:

https://doi.org/10.30442/ahr.1001-09-228

References

Bhatla, N, Aoki, D, Sharma, DN, Sankaranarayanan, R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021; 155(Suppl. 1): 28– 44. https://doi.org/10.1002/ijgo.13865

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209- 249. https://doi.org/10.3322/caac.21660

Makoni M. HPV vaccine roll-out in Nigeria and Bangladesh. Lancet Oncol. 2023;24(12):P1311-1312. https://doi.org/10.1016/S1470-2045(23)00571-5

World Health Organisation. Nigeria to vaccinate 7.7 million girls against leading cause of cervical cancer. 24 October 2023. Available at: https://www.afro.who.int/countries/nigeria/news/nigeria-vaccinate-77-million-girls-against-leading-cause-cervical-cancer. Accessed 10 December 2023.

Ajenifuja KO, Gage JC, Adepiti CA, Wentzensen N, Eklund C, Reilly M, et al. A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. Int J Gynecol Cancer 2013;23(3). https://doi.org/10.1097/IGC.0b013e318280f395

Olarinoye AO, Shiru MM, Ubom AE, Olabinjo AO, Abdul IF, Ijarotimi OA, et al. Knowledge, Attitude and Uptake of Pap Smear among Female Healthcare Professionals in a Nigerian Teaching Hospital. Annals of Health Research. 2021;7(4):391-402. doi:10.30442/ahr.0704-07-149

Stewart TS, Moodley J, Walter FM. 2018. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol 2018; 53: 81-92. https://doi.org/10.1016/j.canep.2018.01.014

Kamath Mulki A, Withers M. Human Papilloma Virus self-sampling performance in low-and middle-income countries. BMC Women’s Health 2021;21:1-11. https://doi.org/10.1186/s12905-020-01158-4

Desai KT, Ajenifuja KO, Banjo A, Adepiti CA, Novetsky A, Sebag C, et al. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage. Infect Agents Cancer 2020;15:60. https://doi.org/10.1186/s13027-020-00324-5

Downloads

Published

2024-03-30

Issue

Vol. 10 No. 1 (2024)

Section

Letter To The Editor

License

Copyright (c) 2024 Annals of Health Research (The Journal of the Medical and Dental Consultants' Association of Nigeria, OOUTH, Sagamu, Nigeria)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.

Most read articles by the same author(s)